Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Trial Identifier: QHD00014
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: September 2020
Primary Completion Date: June 2021
Study Completion Date: June 2021
Condition: Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States, California SAN DIEGO, California, United States, 92123-1881
United States, Florida Miami, Florida, United States, 33142
United States, Georgia Atlanta, Georgia, United States, 30322
United States, Kansas El Dorado, Kansas, United States, 67042
United States, Kentucky BARDSTOWN, Kentucky, United States, 40004
United States, Ohio Dayton, Ohio, United States, 45414
United States, South Carolina Barnwell, South Carolina, United States, 29812
United States, Utah Salt Lake City, Utah, United States, 84107
UNITED STATES, Louisiana New Orleans, Louisiana, UNITED STATES, 70119
UNITED STATES, Utah SALT LAKE CITY, Utah, UNITED STATES, 84121